In the last three months, 8 analysts have published ratings on Gilead Sciences (NASDAQ:GILD), offering a diverse range of perspectives from bullish to bearish.
The table below provides a snapshot of their recent ratings, showcasing how sentiments have evolved over the past 30 days and comparing them to the preceding months.
| Bullish | Somewhat Bullish | Indifferent | Somewhat Bearish | Bearish | |
|---|---|---|---|---|---|
| Total Ratings | 1 | 1 | 6 | 0 | 0 |
| Last 30D | 0 | 0 | 1 | 0 | 0 |
| 1M Ago | 0 | 0 | 0 | 0 | 0 |
| 2M Ago | 1 | 1 | 5 | 0 | 0 |
| 3M Ago | 0 | 0 | 0 | 0 | 0 |
Providing deeper insights, analysts have established 12-month price targets, indicating an average target of $79.5, along with a high estimate of $105.00 and a low estimate of $69.00. A decline of 5.03% from the prior average price target is evident in the current average.
Interpreting Analyst Ratings: A Closer Look
A comprehensive examination of...
Login or create a forever free account to read this news
Sign up/Log in